Plunkett Research Online: ChroMedX

CHROMEDX (CHX:CNQ) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

ChroMedX Corp is a Canadian-based medical technology company. The company is mainly engaged in the business of research, development, and manufacturing of in vitro diagnostics and point-of-care technologies. Its HemoPalm platform provides a combination of full CO-oximetry and blood gases in one hand.....



ChroMedX
Ticker: CHX
Exchange: CNQ
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 647 872-9982
Fax: 844 247-6633
Address: 65 Queen Street West
Suite 520
Toronto, ON M5H 2M5 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Medical Imaging and Electromedical (Medical Devices) Equipment, including MRI, Ultrasound, Pacemakers, EKG and CAT
ContactsDescription

Wayne MaddeverCEO/Director/President
Christopher HopkinsCFO
See More
ChroMedX Corp is a Canadian-based medical technology company. The company is mainly engaged in the business of research, development, and manufacturing of in vitro diagnostics and point-of-care technologies. Its HemoPalm platform provides a combination of full CO-oximetry and blood gases in one hand.....See More See More

Auditor: Davidson & Company LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: